https://www.selleckchem.com/pr....oducts/combretastati
To review and update the latest scientific evidence gathered in recent years regarding prostate-specific antigen (PSA) for better implementation into routine clinical practice. Analysis of the available evidence on the current role of PSA, based on the experience of an expert panel in the subject under analysis. Currently, PSA cannot be considered only as a guide for the presence or absence of prostate cancer. This determination can also help the urologist to decide on the most convenient treatment for a patient with benign pr